Pathological and radiological features of false-positive lesions on [68Ga]Ga-PSMA-11 PET/CT in primary staging of prostate cancer: a radio-pathology matching analysis

被引:0
|
作者
Li, Renjie [1 ,2 ]
Fu, Yao [3 ]
Peng, Shan [3 ]
Yang, Fengjiao [4 ]
Ai, Shuyue [4 ]
Wang, Feng [4 ]
Zhang, Shun [1 ,2 ]
Guo, Hongqian [1 ,2 ]
Qiu, Xuefeng [1 ,2 ]
机构
[1] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Dept Urol,Affiliated Hosp, Nanjing 210008, Peoples R China
[2] Nanjing Univ, Inst Urol, Nanjing 210008, Peoples R China
[3] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Dept Pathol,Med Sch, Nanjing 210008, Peoples R China
[4] Nanjing Med Univ, Nanjing Hosp 1, Dept Nucl Med, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
Ga-68]Ga-PSMA-11 PET/CT; Pathological feature; False-positive; True-negative; True-positive; MULTIPARAMETRIC MRI; EMISSION-TOMOGRAPHY; GA-68-PSMA PET/CT; PI-RADS; DIAGNOSIS; ACCURACY;
D O I
10.1007/s00259-025-07148-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The aim of this study was to investigate the radiological and pathological characteristics of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT during the primary staging of prostate cancer. Methods This study retrospectively analyzed 216 prostate cancer patients who had [Ga-68]Ga-PSMA-11 PET/CT before radical prostatectomy. False-positive lesion was defined as suspicious lesion with PRIMARY score >= 3 on PET/CT but benign on whole-mount pathology. To analyze the radiological and pathological features of false-positive lesions, no-uptake areas on PSMA PET/CT with benign pathology on the whole-mount specimen were randomly delineated and defined as true-negative lesions. The pathological features of false-positive and true-negative lesions were compared using Fisher's exact test. The differences of SUVmax and SUVmean between false-positive and true-positive lesions were determined and compared using the Wilcoxon matched-pairs signed-ranks test. In addition, PSMA expression in false-positive lesions was assessed by immunohistochemistry. Results A total of 36 false-positive lesions were identified on [Ga-68]Ga-PSMA-11 PET/CT: 25 (69.44%) were simple atrophy with cyst formation, 7 (19.44%) were prostatic nodular hyperplasia, 3 (8.33%) were inflammation and 1 (2.78%) was normal glands. A comparable number of 36 true-negative lesions were delineated: 21 (58.33%) were normal glands, 8 (22.22%) were simple atrophy with cyst formation, 6 (16.67%) were prostatic nodular hyperplasia, and 1 (2.78%) were inflammation. The Fisher's exact test revealed a statistically significant difference in the prevalence of simple atrophy with cyst formation between false-positive and true-negative lesions (69.44% vs. 22.22%; P < 0.001). Differences in SUVmax and SUVmean between false-positive and true-positive lesions were also statistically significant (both P < 0.001). PSMA expression in false-positive lesions was confirmed via immunohistochemistry. Conclusion This study determined that simple atrophy with cyst formation is a distinctive pathological feature of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT. This observation is likely attributable to the elevated PSMA expression in simple atrophy with cyst formation, as confirmed by histological analysis. Additionally, false-positive lesions were found to have significantly lower SUV compared to true-positive lesions.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis
    Kimura, Shoji
    Abufaraj, Mohammad
    Janisch, Florian
    Iwata, Takehiro
    Parizi, Mehdi Kardoust
    Foerster, Beat
    Fossati, Nicola
    Briganti, Alberto
    Egawa, Shin
    Hartenbach, Markus
    Shariat, Shahrokh F.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (01) : 1 - 10
  • [42] Prediction of T staging in PI-RADS 4–5 prostate cancer by combination of multiparametric MRI and 68Ga-PSMA-11 PET/CT
    Yuanzhen Ding
    Chenghao Mo
    Qiubo Ding
    Tingsheng Lin
    Jie Gao
    Mengxia Chen
    Wenfeng Lu
    Jiyuan Sun
    Feng Wang
    Shiming Zang
    Qing Zhang
    Shiwei Zhang
    Hongqian Guo
    BMC Urology, 23
  • [43] Intra-individual comparison of 68Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer
    F. L. Giesel
    F. Sterzing
    H. P. Schlemmer
    T. Holland-Letz
    W. Mier
    M. Rius
    A. Afshar-Oromieh
    K. Kopka
    J. Debus
    U. Haberkorn
    C. Kratochwil
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1400 - 1406
  • [44] Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
    Kuten, Jonathan
    Fahoum, Ibrahim
    Savin, Ziv
    Shamni, Ofer
    Gitstein, Gilad
    Hershkovitz, Dov
    Mabjeesh, Nicola J.
    Yossepowitch, Ofer
    Mishani, Eyal
    Even-Sapir, Einat
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (04) : 527 - 532
  • [45] Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients
    Uprimny, Christian
    Bayerschmidt, Steffen
    Kroiss, Alexander Stephan
    Fritz, Josef
    Nilica, Bernhard
    Svirydenka, Anna
    Decristoforo, Clemens
    di Santo, Gianpaolo
    von Guggenberg, Elisabeth
    Horninger, Wolfgang
    Virgolini, Irene Johanna
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (01) : 123 - 133
  • [46] PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
    Hoffmann, Manuela Andrea
    Buchholz, Hans-Georg
    Wieler, Helmut J.
    Miederer, Matthias
    Rosar, Florian
    Fischer, Nicolas
    Mueller-Huebenthal, Jonas
    Trampert, Ludwin
    Pektor, Stefanie
    Schreckenberger, Mathias
    CANCERS, 2020, 12 (02)
  • [47] Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer
    Zhang, Qing
    Zang, Shiming
    Zhang, Chengwei
    Fu, Yao
    Lv, Xiaoyu
    Zhang, Qinglei
    Deng, Yongming
    Zhang, Chuan
    Luo, Rui
    Zhao, Xiaozhi
    Wang, Wei
    Wang, Feng
    Guo, Hongqian
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [48] Whole-Body Integrated [68Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference
    Guberina, Nika
    Hetkamp, P.
    Ruebben, H.
    Fendler, W.
    Grueneisen, J.
    Suntharalingam, S.
    Kirchner, J.
    Puellen, L.
    Harke, N.
    Radtke, J. P.
    Umutlu, L.
    Hadaschik, B. A.
    Herrmann, K.
    Forsting, M.
    Wetter, A.
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (03) : 788 - 796
  • [49] A pictorial view on false positive findings of 68Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable PSA values
    Dancheva, Zhivka
    Chausheva, Sophiya
    Stoeva, Tanya
    Dyankova, Marina
    Yordanova, Tsvetelina
    Chaushev, Borislav
    Marinov, Rostislav
    Nikolov, Viktor
    Abushev, Pavel
    Todorov, Georgi
    Dimitrova, Eleonora
    Lisarova, Aneliya
    Anakievski, Deyan
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2024, 27 (01) : 16 - 26
  • [50] 68Ga-PSMA-11 PET and mpMRI in the diagnosis of initial lymph node staging of prostate cancer: a head-to-head comparative meta-analysis
    Wang, Yuanrong
    Jing, Ren
    Wang, Haiyan
    Zhao, Qiuyan
    FRONTIERS IN MEDICINE, 2024, 11